Risbridger G - Search Results

1

Informing men about prostate cancer screening: a randomized controlled trial of patient education materials.

Ilic D, Egberts K, McKenzie JE, Risbridger G, Green S. Ilic D, et al. Among authors: risbridger g. J Gen Intern Med. 2008 Apr;23(4):466-71. doi: 10.1007/s11606-007-0466-z. J Gen Intern Med. 2008. PMID: 18373146 Free PMC article. Clinical Trial.

2

Searching the Internet for information on prostate cancer screening: an assessment of quality.

Ilic D, Risbridger G, Green S. Ilic D, et al. Among authors: risbridger g. Urology. 2004 Jul;64(1):112-6. doi: 10.1016/j.urology.2004.02.027. Urology. 2004. PMID: 15245946

3

Systematic Review Links the Prevalence of Intraductal Carcinoma of the Prostate to Prostate Cancer Risk Categories.

Porter LH, Lawrence MG, Ilic D, Clouston D, Bolton DM, Frydenberg M, Murphy DG, Pezaro C, Risbridger GP, Taylor RA. Porter LH, et al. Among authors: risbridger gp. Eur Urol. 2017 Oct;72(4):492-495. doi: 10.1016/j.eururo.2017.03.013. Epub 2017 Mar 22. Eur Urol. 2017. PMID: 28342640 Review.

4

Neuroendocrine cells in prostate cancer correlate with poor outcomes: a systematic review and meta-analysis.

Kannan A, Clouston D, Frydenberg M, Ilic D, Karim MN, Evans SM, Toivanen R, Risbridger GP, Taylor RA. Kannan A, et al. BJU Int. 2022 Oct;130(4):420-433. doi: 10.1111/bju.15647. Epub 2021 Dec 5. BJU Int. 2022. PMID: 34784097 Review.

5

Elevated expression of inhibin alpha in prostate cancer.

Risbridger GP, Shibata A, Ferguson KL, Stamey TA, McNeal JE, Peehl DM. Risbridger GP, et al. J Urol. 2004 Jan;171(1):192-6. doi: 10.1097/01.ju.0000100048.98807.b7. J Urol. 2004. PMID: 14665874

6

Aromatase and prostate cancer.

Ellem SJ, Risbridger GP. Ellem SJ, et al. Among authors: risbridger gp. Minerva Endocrinol. 2006 Mar;31(1):1-12. Minerva Endocrinol. 2006. PMID: 16498360 Review.

7

Breast and prostate cancer: more similar than different.

Risbridger GP, Davis ID, Birrell SN, Tilley WD. Risbridger GP, et al. Nat Rev Cancer. 2010 Mar;10(3):205-12. doi: 10.1038/nrc2795. Epub 2010 Feb 11. Nat Rev Cancer. 2010. PMID: 20147902 Review.

8

The complexities of identifying a cell of origin for human prostate cancer.

Risbridger GP, Taylor RA. Risbridger GP, et al. Asian J Androl. 2011 Jan;13(1):118-9. doi: 10.1038/aja.2010.114. Epub 2010 Oct 18. Asian J Androl. 2011. PMID: 20953202 Free PMC article. No abstract available.

9

To target or not to target the enemy within localized prostate cancer.

Risbridger G, Taylor R. Risbridger G, et al. Cell Cycle. 2013 Nov 1;12(21):3349-50. doi: 10.4161/cc.26576. Epub 2013 Sep 23. Cell Cycle. 2013. PMID: 24091534 Free PMC article. No abstract available.

10

Establishing a cryopreservation protocol for patient-derived xenografts of prostate cancer.

Porter LH, Lawrence MG, Wang H, Clark AK, Bakshi A, Obinata D, Goode D, Papargiris M, Mural, Clouston D, Ryan A, Norden S, Corey E, Nelson PS, Isaacs JT, Grummet J, Kourambas J, Sandhu S, Murphy DG, Pook D, Frydenberg M, Taylor RA, Risbridger GP. Porter LH, et al. Among authors: risbridger gp. Prostate. 2019 Aug;79(11):1326-1337. doi: 10.1002/pros.23839. Epub 2019 Jun 18. Prostate. 2019. PMID: 31212368

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

285 results

Search Page

Filters